To systematically identify and synthesize investigations of the effectiveness of occlusive skin wrap for reducing heat loss in premature infants born at less than 36 weeks gestations.
INTRODUCTION
Hypothermia has been recognized as an independent risk factor for death in newborn infants for more than 40 years.
1,2 Despite modern resuscitation techniques, 40 to 50% of premature newborns experience hypothermia. [2] [3] [4] Very immature infants are particularly vulnerable to heat loss because they lack subcutaneous fat, have an increased surface area to body weight ratio, exhibit poor vasomotor control in the first two or three days of life, and have immature stratum corneum that is relatively deficient in keratin content. 5, 6 Risk factors associated with neonatal hypothermia include morbidity from infection, abnormal coagulation, postdelivery acidosis, delayed readjustment from the fetal to newborn circulation, and respiratory distress syndrome. 2 It is recognized that heat loss is the greatest in the first few minutes of life, since infants are born wet into a relatively cool environment. Presently, the standard of care for reducing heat loss following birth, as described by the Neonatal Resuscitation Program (NRP), is to immediately dry all newborns under radiant heat. 7 Although this method has been shown to significantly reduce heat loss, there is still considerable room for improvement. One method that has shown promise for reducing postnatal temperature decline and that is becoming widely adopted 8 is occlusive skin wrapping of the wet newborn under a radiant heater. 4, [9] [10] [11] [12] [13] [14] Instead of drying, the infant is immediately wrapped from the shoulders down with transparent wrap under a radiant warmer and their head is dried. Typically, the infant is kept in the wrap until they are admitted to the neonatal intensive care unit, where it is removed under a radiant warmer or after the infant has been placed in a warmed humidified incubator. While this method is becoming widely adopted, evidence regarding its effect on heat loss prevention as well as on mortality and morbidity is limited. As such, there is a need to investigate the impact of wrapping on heat loss prevention as well as mortality and morbidity.
Purpose
To systematically review the evidence for the effect of occlusive skin wrapping on reducing heat loss in premature infants. Secondary outcomes including mortality will also be investigated.
METHODS

Study Identification
A comprehensive search was conducted to identify all relevant studies regardless of publication status. The following electronic databases were searched: Medline (1966 ( -March 2003 , EMBASE (1980 -March 2003 , Web of Science, and EBM reviews first quarter (2003) (search strategies available upon request). The primary authors of relevant studies and experts in the area of neonatology were contacted for information on additional studies. In addition, reference lists of relevant studies were examined.
Study Selection
Two reviewers independently screened the search output to identify potentially relevant studies. These studies were assessed for inclusion using the following predetermined eligibility criteria: (i) types of studies: primary investigation; (ii) population: premature infants born before 36 weeks gestation; (iii) intervention: occlusive transparent skin wrap applied immediately following delivery; (iv) comparison: standard of care; (v) outcome: temperature.
Assessment of Methodological Quality
Two reviewers independently assessed the quality of the RCTs using the validated 5-point Jadad scale. 15 Allocation concealment was also assessed. 16 Discrepancies were resolved by consensus. The quality of observational studies was not assessed, since quality ratings would not distinguish among them. 17 
Data Extraction
One reviewer used a standard data extraction form to extract the data and a second checked for accuracy. The following data were extracted: study design, age of participants, type of wrap (e.g., polyethylene), and results. When data were missing or unclear, additional information was requested from the authors. The primary outcome was temperature at admission to the NICU. Secondary outcomes included death, incidence of hypothermia, respiratory problems (e.g., highest FiO 2 ), and neurological problems (e.g., major brain injury). Data on reported complications and adverse events (e.g., hyperthermia) were also collected.
Statistical Analysis
The following data manipulations were performed to create a functional data set: when only medians were reported they were included in the meta-analysis as though there were means; corresponding standard deviations (SDs) were imputed from ranges using tabled empirical results created by Pearson, 18 from interquartile ranges by dividing the width of the range by 1.35 19 or by using a direct substitution (i.e., using an SD from another included study on the same outcome).
Review Manager 4.2 (Cochrane Collaboration, 2003) was used to calculate and pool risk ratios (RR) for dichotomous results and weighted mean differences (WMD) for continuous variables. The risk difference was used for dichotomous data when an event (e.g., hyperthermia) did not occur in either group. To enhance clinical interpretation, the number needed to treat (NNT) was also calculated. Statistical heterogeneity was quantified using the I 2 statistic. 20 The results were analyzed using random and fixed effects. Fixed effects results are reported only when the statistical significance is different from the random effects results. Summary estimates were pooled using inverse-variance weights for continuous data and Mantel-Haenszel weights for dichotomous data.
The following important covariates were selected a priori for exploration: gestational age, birth weight, delivery room temperature, maternal temperature, time of transfer from delivery room to NICU (i.e., admission age/time of wrap removal), and route of temperature measurement (i.e., rectal or axillary). Individual patient data were acquired for these variables where available. These data were used to perform multiple linear regression analyses adjusting for trial status as a fixed effect. All possible models using only linear effects and two-way interactions were considered. Model diagnostics were examined. Route of temperature measurement was not analyzed since it was confounded with study design and too few studies were included to perform between-study analyses. Publication bias was not assessed due to the small number of studies.
The use of HCTs can lead to erroneous conclusions about the efficacy of a treatment 17 because they introduce bias in a number of ways, particularly in how the treatment is selected. Despite this potential bias, HCTs were included to increase power in the mortality analysis. Accordingly, analyses were also conducted for each outcome by study design (i.e., RCT or HCT) as well as for both study designs combined. Figure 1 illustrates the flow of identification and inclusion of studies. Eight studies met inclusion criteria; three were randomized controlled trials (RCT) 4, 9, 21 and five were historical controlled trials (HCT). [10] [11] [12] [13] [14] Reasons for excluding potentially relevant studies include the following: infants were not wrapped immediately following birth; [22] [23] [24] [25] [26] infants were not wrapped with a plastic covering; 27 and/or the study was not a primary investigation.
RESULTS
Description of Studies
27,28
The studies varied with respect to year of publication, number of participants, gestational age of participants, type of occlusive skin wrap (e.g., polyethylene), outcome measures, and definition of hypothermia (Table 1) . Overall, 278 infants were treated with occlusive skin wrap (95 RCT, 180 HCT) and 720 infants received standard care (105 RCT, 627 HCT). Five studies (three RCTs and two HCTs) 4, 9, 11, 14, 21 included data for infants <29 weeks gestation and four studies (one RCT and three HCTs) 4, 10, 12, 13 included data for infants <33 weeks gestation. The majority (five) of the studies investigated occlusive skin wrap made from polyethylene. Admission temperature was the primary outcome in seven of the studies; incidence of hypothermia, a surrogate of admission temperature, was the primary outcome in one study. Secondary outcomes included mortality, duration of hospitalization, and major brain injury.
The quality of the RCTs ranged from 1 to 2. The maximum Jadad score was three rather than the conventional five since, due to the nature of the intervention, the studies could not be doubleblinded. Two of the RCTs were conducted in Canada and one was conducted in the United States, and the HCT that was published as a full study was conducted in France. The remaining four HCTs were published as letters and were conducted in Sweden, the United Kingdom (2), and New Zealand. All three RCTs received independent peer reviewed funding.
Admission Temperature
All eight studies (three RCTs and five HCTs) 4, [9] [10] [11] [12] [13] [14] 21 reported outcome data on admission temperature for infants between 23 and 33 weeks gestation. The RCT (200 infants) and HCT data (807 infants) show statistically significant differences for admission temperature between wrapped and unwrapped infants (Figure 2 ; RCT ¼ WMD 0.631C, 95% confidence interval (CI) 0.38, 0.87; HCT ¼ 0.961C, 95% CI 0.66, 1.27) . A large amount of heterogeneity was found among the HCTs (I 2 ¼ 83%) for this outcome.
Authors of all three RCTs and two of the HCTs provided individual patient data for several variables; only two RCT authors (126 infants) provided all of the requested variables (i.e., admission temperature, treatment, gestational age, delivery room temperature, maternal temperature, and admission age). A linear regression was performed between admission temperature (range from 32.1 to 38.51C) as the dependent variable and treatment status (wrap vs no wrap), gestational age (from 23 to 33 weeks), delivery room temperature (from 18 to 31.11C), maternal temperature (from 35.6 to 39.41C), and admission age (from 0 to 54 minutes) as independent variables. The model included a trial term (i.e., RCT vs HCT) as a fixed effect. All model assumptions were met. Admission age was significant when investigated alone but not in the presence of the other variables, and thus was not included in the model. The model is summarised in Table 2 (R 2 ¼ 30%). Older infants, warmer mothers, warmer delivery rooms, and wrapped infants all show statistically significant positive associations with higher admission temperatures. A significant negative interaction was found between treatment and gestational age ( Table 2) .
A second model was fit with birth weight instead of gestational age. The strong correlation between these two variables (r ¼ 0.69) prevented both from being included in the same model. Birth weight showed a stronger relationship with admission temperature than gestational age; however, since birth weight cannot be determined antenatally, it was not included in the primary model.
Incidence of Hypothermia
Three studies (one RCT and two HCTs) 9,10,13 reported on the incidence of hypothermia. The HCTs defined hypothermia as <35.51C and the RCT defined it as <36.41C. Since we had Articles included (n=8) Figure 1 . Progress through the stages of systematic review. individual patient data from two additional RCTs, we were able to calculate the incidence of hypothermia in these studies. For these studies hypothermia was defined as <36.51C based on the World Health Organization's (WHO) definition. 29 The results of the RCTs show significantly fewer wrapped infants (203 infants) experienced hypothermia than unwrapped infants (RR 0.51, 95% CI 0.37, 0.71; NNT 2.9, 95%CI 2.3, 4.9). The RR for the HCTs (398 infants) was larger in magnitude (RR 0.32, 95% CI 0.08, 1.24; NNT 3.1, 95%CI 2.3, infinity) than for the RCTs, yet it was not statistically significant and was quite heterogeneous (I 2 ¼ 86%). The fixed effects model for the HCT data shows significantly fewer wrapped babies experienced hypothermia than unwrapped babies (RR 0.38, 95% CI 0.25, 0.58).
Mortality
Seven studies (three RCTs; four HCTs) reported on mortality.
4,9-11,13,14,21 A statistically significant difference was not found between wrapped and unwrapped infants in the RCTs (Figure 3 ; RR 0.72, 95% CI 0.36, 1.45; NNT 14.8, 95% CI 6.5, infinity) or in the HCTs (0.76, 95% CI 0.51, 1.13; NNT 16.1, 95% CI 7.9, infinity). There was little heterogeneity among any of the studies (I 2 ¼ 3% for RCTs and 0% for HCTs). Figure 2. Admission temperature. RCT, Knobel et al. 9 found that the occurrence of major brain injury (i.e., sonographic evidence of intraventricular hemorrhage with ventricular dilation, parenchymal hemorrhagic infarction, or periventricular leukomalacia) was similar between groups (13% wrapped vs 12% unwrapped). 9 Similarly, in their HCT, Bjorklund et al. 14 found that the incidence of major intracranial pathologies (i.e., grades 3 and 4 intraventricular hemorrhage and perventricular leukomalacia) did not significantly differ between wrapped and unwrapped infants.
Respiratory Outcomes
Length of Stay
Knobel et al. 9 (88 infants) investigated the duration of hospital stay and found it did not significantly differ between wrapped and unwrapped infants (MD À6.8 days, 95% CI À21.9, 8.3).
Adverse Effects
Three RCTs 4,9,21 (200 infants) and two HCTs 10,13 (398 infants) reported data on the incidence of hyperthermia. Meta-analysis found the incidence of hyperthermia did not significantly differ between wrapped and unwrapped infants (RCTs RD 2%, 95% CI À2, 6; HCTs 6, 95% CI À16, 27). There was no heterogeneity among the RCTs; however. a large amount existed between the HCTs (I 2 ¼ 95%). Lyon and Stenson 11 reported ''mildly raised temperatures'' in ''some'' of the wrapped infants; however, they did not report a definition for a ''raised temperature'', the number of infants that experienced these temperatures, or the outcome of those who experienced such temperatures.
Vohra et al. 4 investigated the incidence of infection, skin maceration, and interference with resuscitation and reported that none of the infants (wrapped or unwrapped) experienced any of these adverse events.
DISCUSSION
The results of this review confirm that when used in conjunction with a radiant warmer, occlusive skin wrap is effective for reducing heat loss in premature infants. Meta-analysis of the RCT and HCT data shows wrapping significantly increases admission temperature. In fact, meta-analysis of the RCT data found a mean increase of 0.631C. Given the optimal temperature for term infants only has a range of 11C (range is from 36.5 to 37.51C), 29 moving a population mean by more than half a degree is both clinically and statistically significant. The impact wrapping has on reducing heat loss is further supported by meta-analysis of RCT evidence that showed significantly fewer wrapped infants experienced hypothermia than unwrapped infants. A significant negative interaction was found between treatment and gestational age providing evidence to suggest the effect of the wrap is limited by age. That is, when compared to the standard of care, wrapping is more effective at reducing heat loss in younger infants but not in older infants. This is supported by the fact that younger infants have less subcutaneous fat and an increased surface area to body weight ratio and are thus more vulnerable to heat loss than older infants.
The World Health Organization (WHO) recommends delivery room temperature to be kept at 26 in warmer delivery rooms had higher admission temperatures. As both wrapping and delivery room temperature are associated with reducing heat loss in premature infants, it can be suggested that the optimal method for preventing heat loss in premature infants is to combine the use of occlusive skin wrap with a warm delivery room. Also, it can be suggested the wrap will have a greater benefit in the clinical setting since despite WHO guidelines, it is difficult to achieve delivery room temperatures in the recommended range, even when best efforts are made to do so. 9 For more than 40 years, hypothermia has been recognized as an independent risk factor for death in newborn premature infants. 13 Therefore, it can be hypothesized that reducing heat loss in premature infants will reduce mortality. Meta-analysis of the available data was unable to demonstrate a significant reduction in mortality associated with wrapping premature infants. The inability to demonstrate a significant effect indicates one of two things: either a lack of power for detecting a mortality difference, or wrapping does not significantly reduce mortality in premature infants. The CI for this outcome includes clinically relevant values (RR 0.72, 95% CI 0.36, 1.45) that may indicate a relative risk reduction in mortality as large as 64%. This indicates that we cannot rule out the possibility wrapping significantly reduces mortality in premature infants. Additional RCTs with larger sample sizes are required to adequately assess the effect of occlusive skin wrap on mortality.
The risk of overheating (i.e., hyperthermia) is a potential concern associated with the use of occlusive skin wrap. 13 Although a formal evaluation of the relationship between wrapping and hyperthermia has not been conducted, five of the included studies report on this outcome. Surprisingly, the existing evidence suggests that infants treated with wrap are as likely to experience hyperthermia as infants who are treated according to the standard of care. In fact, in studies where infants were found to experience hyperthermia, the rise in temperature was associated with factors other than the wrap including maternal infection and temperature. Further research is required to reveal the relation between occlusive skin wrapping and hyperthermia.
Limitations of this systematic review include the use of nonRCTs, which can increase bias and lead to erroneous conclusions about the safety and efficacy of a treatment. 17 To protect against this, we analyzed RCT and HCT data separately. Overall, the results of the meta-analyses of RCT and HCT evidence agreed in direction of effect. Lack of blinding of the intervention is another potential limitation of the included studies, but this was mitigated by the use of an objective primary outcome (i.e., admission temperature) that is less susceptible to bias. Of note, the use of admission temperature may not be the best measure for assessing the impact of hypothermia on premature infants. Admission temperature likely underestimates the incidence of hypothermia, particularly in studies where there is no standardization of the order in which admitting procedures are conducted or when temperature is actually measured. More important measures may include the infant's lowest temperature and assessment of the duration of hypothermia.
CONCLUSION
This systematic review supports the use of occlusive skin wrap for preventing heat loss in premature infants. The meta-analysis lacked the power to provide definitive results regarding the effect of occlusive wrap on mortality. No serious adverse events have been reported to date, but sample sizes have been small. Since the direction of effect on mortality was consistent in favor of wrap, we support a larger trial to investigate the effect of occlusive skin wrapping on mortality. A larger definitive study should also include neurodevelopmental follow-up and assess both short-and longterm consequences of preventing heat loss in premature infants. Based on mortality data from the Vermont Oxford Network (VON) that shows a 22.7% mortality risk for infants born at 24 þ 0 to 27 þ 6 weeks gestation taken in conjunction with this review that shows a 27% reduction in mortality, the optimal trial would require 1604 infants (802 per group) to achieve 80% power for detecting a 25% reduction in mortality. Such a study is presently underway in conjunction with the VON. 31 Given wrapping of premature infants has become widely adopted 8 and evidence suggests that it prevents heat loss, future editions of the neonatal resuscitation program
